Drug · DIN 02283697
METHOTREXATE
Authorized, not yet reported as sold
Authorized for sale in Canada; the company has not yet told Health Canada that it is on the market.
Status Approved since March 21, 2019.
- Drug Identification Number (DIN)
- 02283697
- Company (DIN owner)
- Apotex Inc.Toronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Methotrexate L01BA01
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| METHOTREXATE (METHOTREXATE SODIUM) | 2.5 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- July 14, 2006: NOC 8148Abbreviated New Drug Submission (ANDS)
Other DINs named METHOTREXATE
- DIN 02170671 · Cancelled Post Market